Proton pump inhibitors and risk of gastric cancer in a case–control study
In order to reduce the latency bias, subjects whose first-time prescriptions for proton pump inhibitors were noted ≤12 months before the index date were excluded from the study. [...]only those subjects whose first-time prescriptions for proton pump inhibitors were noted >12 months before the ind...
Saved in:
Published in | Gut Vol. 68; no. 4; pp. 765 - 767 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
BMJ Publishing Group LTD
01.04.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | In order to reduce the latency bias, subjects whose first-time prescriptions for proton pump inhibitors were noted ≤12 months before the index date were excluded from the study. [...]only those subjects whose first-time prescriptions for proton pump inhibitors were noted >12 months before the index date could be included. The latency bias could be reduced. [...]subjects included were those who needed proton pump inhibitors to treat their acid-related GI diseases rather than gastric cancer-related symptoms. Because stringent inclusion and exclusion criteria were applied, the eligible subject number was small. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Correspondence-1 ObjectType-Commentary-3 content type line 23 |
ISSN: | 0017-5749 1468-3288 1468-3288 |
DOI: | 10.1136/gutjnl-2018-316371 |